 | Purchase deal with firms only after Covid-19 vaccines prove effective: CentreAt present, vaccine candidates by Bharat Biotech, Serum Institute of India (Oxford University-AstraZeneca), and Zydus Cadila are under advanced stages of trials. |
 | Hoping to receive 50 crore doses of COVID-19 vaccine by July: Harsh VardhanThe minister also said that the government is keeping an eye on immunity data with regard to Covid-19 disease while finalizing these plans, as reported by this newspaper earlier. |
 | Will Centre have Rs 80,000 crore for distribution of COVID-19 vaccine, asks Serum Institute CEOThe central health ministry official said that they have not received any official proposal from the institute regarding mass production, procurement, and distributions of the vaccine. |
 | Seven volunteers found ineligible for coronavirus vaccine trial due to 'medical reasons''All seven candidates who were selected on Monday have become ineligible due to various medical reasons, including antibody test coming positive for some,' said Dr Murlidhar Tambe. |
| Phase-III human clinical trial of Oxford COVID-19 vaccine begins in PuneUnder phase-II, trials had been conducted at the Bharti Vidyapeeth Medical College and also KEM Hospital in the city. |
 | Phase-III trial of Oxford vaccine to begin in Pune next weekUnder phase-II, trials were conducted at Bharti Vidyapeeth Medical College and also KEM Hospital in the city. |
 | Covid-19 vaccine likely by early 2021 but will take time to reach all: Harsh VardhanUnder PM Modi's guidance, an expert group is looking at it and we have advanced planning in place, the Union Health Minister said. |
 | Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccineSII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events. |
 | Oxford vaccine trial stopped after volunteer developed neurological symptoms: AstraZenecaThe study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent. |
 | Mysuru: Oxford vaccine trials halted in UK, but JSS institute's trials going fineHowever, speaking to TNIE, B Suresh, Pro Chancellor of JSS AHER, said that so far, none among their 32 volunteers have reported any adverse reactions and all are doing fine. |
 | India will continue Oxford vaccine trial, says Serum Institute after illness in volunteer pauses trial abroadSerum Institute of India, under whose aegis the vaccine is to be being tried on 1,600 participants across 17 centres, said that trials in India will continue, irrespective of the latest development. |
 | COVID-19 vaccine human trial: Vital signs of volunteers normal, says doctorIn all, 25 candidates will be given the vaccine in the next seven days. |
 | If everything goes well India would get COVID-19 vaccine by year-end: Harsh VardhanThree COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India. |
 | Oxford Covid-19 vaccine to cost Rs 225 per dose in India: Serum InstituteThe vaccine candidate is under advanced stages of clinical trials and likely to be available for public use in the first half of 2021. |
 | ICMR says two COVID-19 vaccines on phase 2 trial now but researchers differPrincipal Investigators involved in the vaccine trial said that it will take at least a month for the first phase of the trial to be completed. |
